Feature | January 05, 2021

Most Popular Cardiology Technology Content in December 2020

The most popular DAIC content in December 2020 included the Boston Scientific Lotus TAVR valve being taken off the market, CMS approving expanding coverage of LVADs for more Medicare patients and numerous COVID-19 related cardiology stories and videos.

The most popular DAIC content in December 2020 included the Boston Scientific Lotus TAVR valve being taken off the market, CMS approving expanding coverage of LVADs for more Medicare patients and numerous COVID-19 related cardiology stories and videos.

January 5, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of December 2020. This is based on the website’s record 550,357 pageviews for the month. 

1. Image Gallery Showing Impact of the COVID-19 Pandemic

2. COVID-19 Patients With Cardiovascular Disease Have In-hospital Mortality Rates of 25 to 38 Percent

3. GE Introduces Robotic Angiography Gantry That Addresses Ergonomic Issues

4. VIDEO: What Are The Long-term Cardiac Impacts of COVID-19 Infection —Interview with Todd Hurst, M.D.

5. American Heart Association 2020 Late-breaking Trial Presentations

6. VIDEO: Video Game Helps Diagnose COVID-19 Patients and Manage Their Cardiac Complications — Interview with Eric Gantwerker, M.D.

7. VIDEO: How to Reduce COVID Exposure, Speed Exams and Cut Readmissions in Cardiology Departments — Interview with Keith Ellis, M.D.

8. VIDEO: Abiomed Highlights Trends and New Technology in Hemodynamic Support — Interview with Chuck Simonton, M.D.

9. Most Popular Cardiology Technology Content in November 2020

10. VIDEO: Intravascular Lithotripsy to Treat Severely Calcified Coronary Artery Lesions

11. TAVR Is Now Dominant Form of Aortic Valve Replacement in the United States

12. Cardiac Monitoring in the Time of COVID-19: Next Generation Wearable ECG Technology Comes into Its Own

13. VIDEO: Screening for Atrial Fibrillation Using Single Lead ECG in the VITAL-AF Trial — Interview with Steven Lubitz, M.D.

14. COVID-19 Can Impact Hearts in Young Children

15. Boston Scientific Pulls Lotus Edge TAVR Valve Off The Market

16. VIDEO: Lingering Myocardial Involvement After COVID-19 Infection — Interview with Aaron Baggish, M.D.

17. Video Demonstrations of How Cardiovascular Technology Works

18. CMS Updates Coverage Policies for Artificial Hearts and Ventricular Assist Devices

19. Top 25 Stories in Cardiology in 2020

20. FDA Clears First AI-Powered Algorithm Suite for Personal ECG Monitoring

 

Related Popular Cardiology Technology Content: 

Top 25 Stories in Cardiology in 2020

Top 25 Cardiology Videos on DAIC in 2020

Most Popular Cardiology Technology Content in November 2020

Most Popular Cardiology Technology Content in October 2020

Most Popular Cardiology Technology Content in September 2020

Most Popular Cardiology Technology Content in July 2020

Most Popular Cardiology Technology Content in June 2020

Most Popular Cardiology Technology Content in May 2020

Most Popular Cardiology Technology Content in March 2020

Top 25 Cardiology Videos on DAIC in 2019

The Most Popular Cardiology Topics in 2019

Related Content

Who Can Get the COVID-19 Vaccine? Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, a nurse at a hard-hit nursing home in Michigan, received her first dose just before Christmas.

Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, OTR/L, director of rehabilitation at a hard-hit nursing home in Michigan, received her first dose just before Christmas.

News | Coronavirus (COVID-19) | January 04, 2021 | Dave Fornell, Editor
The Centers for Disease Control and Prevention (CDC) Dec.
Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al.

Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al. 

Feature | Coronavirus (COVID-19) | December 23, 2020
December 23, 2020 — Three clinical trial platforms working together to test the effects of full doses of anticoagulan
The FDA December 18 issued an emergency use authorization (EUA) for a second COVID-19 vaccine from Moderna for use in individuals 18 years of age and older. #COVID19 #SARSCoV2 #Vaccine

The FDA December 18 issued an emergency use authorization (EUA) for a second COVID-19 vaccine from Moderna for use in individuals 18 years of age and older.

News | Coronavirus (COVID-19) | December 23, 2020
December 23, 2020 — The U.S.
Coronavirus SARS-CoV-2 colorized scanning electron micrograph of a cell (pink) heavily infected with SARS-CoV-2 virus particles (teal and purple), isolated from a patient sample. Image courtesy of NIAID. MIS-C Multisystem inflammatory syndrome in children. #COVID19

Coronavirus SARS-CoV-2 colorized scanning electron micrograph of a cell (pink) heavily infected with SARS-CoV-2 virus particles (teal and purple), isolated from a patient sample. Image courtesy of NIAID.

News | Coronavirus (COVID-19) | December 22, 2020
December 22, 2020 — An observational study has launched to evaluate the short- and long-term health outcomes of SARS-
The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec, 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance.  #COVID #COVID19 #SARSCoV2 #vaccine #COVIDVaccine

The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec. 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance. 

Feature | Coronavirus (COVID-19) | December 14, 2020 | Dave Fornell, Editor
December 14, 2020 — The U.S.
cyanosis, cyantosis COVID-positive infant.

Chest X-ray of a  2-month-old infant diagnosed with COVID-19 showing an enlarged heart, bibasilar opacities caused by collapse of the lower sections of lungs, and right upper lobe atelectasis (lung collapse). Find more information and figures on this patient case.

 

News | Coronavirus (COVID-19) | December 02, 2020
December 2, 2020 — A 2-month-old infant diagnosed with...
Results from study of more than 14,000 patients across the United States show the heavy impact of cardiac disease on hospitalized COVID patients. COVID-19 patients with cardiovascular diseases have in-hospital mortality rates of between 25 to 38 percent. #AHA #AHA20 #AHA2020 #COVID19 #Coronavirus #SARSCoV2

Results from study of more than 14,000 patients across the United States show the heavy impact of cardiac disease on hospitalized COVID patients. COVID-19 patients with cardiovascular diseases have in-hospital mortality rates of between 25 to 38 percent. 

News | Coronavirus (COVID-19) | November 18, 2020 | Dave Fornell, Editor
November 18, 2020 — A late-breaking study at the 2020 American Heart A...
Black patient being tested for COVID-19 using a nasal swab PCR test. black adults with COVID-19 were far more likely to be hospitalized than their white counterparts according to data from the AHA COVID-19 Cardiovascular Disease Registry. #AHA #AHA20 #AHA2020 #COVID19 #SARSCoV2

Black patient being tested for COVID-19 using a nasal swab PCR test. Black adults with COVID-19 were far more likely to be hospitalized than their white counterparts according to new data from the AHA COVID-19 Cardiovascular Disease Registry. 

Feature | Coronavirus (COVID-19) | November 18, 2020
November 18, 2020 -- A new American Heart Association (AHA) collab